Merck acquires OncoImmune to ramp supply of promising Covid-19 drug
November 23, 2020 at 06:46 AM EST
The medicine, referred to as CD24Fc, was shown to reduce the risk of respiratory failure or death by more than 50% in patients hospitalized with Covid-19 and requiring oxygen
